Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanctura XR in OAB refractory to Detrol LA
NCT01089751Phase 4Completed
- Sponsor
- Allergan
- Start
- Mar 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trospium in overactive bladder (OAB), sponsored by Allergan. Started Mar 2010; status: completed.
02
Drugs
trospium
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01089751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01089751.